-
Addressing Payer Concerns: Opportunities for HEOR in Orphan Drug Development
Sep 9, 2025, 16:22 PM -
Psychometric Validation of the Mucopolysaccharidosis Health Assessment Questionnaire (MPS-HAQ) for Mucopolysaccharidosis IVA
Sep 9, 2025, 16:22 PM -
Predicting Self-Efficacy in Managing Type 2 Diabetes: Results From a Low-Income, Less Educated Community of Quetta City, Pakistan
Sep 9, 2025, 16:22 PM -
The Value Flower in Bloom: Emerging Recognition of Uncaptured Benefits in NICE HTA Decisions
Sep 9, 2025, 16:22 PM -
Why TSD26 Matters: How Accurate Was Clinical Expert Opinion in Estimating Long-Term Outcomes?
Sep 9, 2025, 16:22 PM -
Exploring Factors Associated With Online Food Delivery Behavior Among Young Adults
Sep 9, 2025, 16:22 PM -
Cost-Utility Analysis of Add-On Vericiguat to Standard Treatment in Thai Patients With Heart Failure and Reduced Ejection Fraction
Sep 9, 2025, 16:22 PM -
The Unique Value of Detecting Preeclampsia: Comparing Health Economic Analyses of Novel Diagnostics With the ISPOR Value Flower
Sep 9, 2025, 16:22 PM -
The Relevance of the Use of TENS Devices in the Therapy of Poststroke Dysphagia
Sep 9, 2025, 16:22 PM -
Survey of Depression Literacy and Help-Seeking Behavior Among Secondary School Students
Sep 9, 2025, 16:22 PM -
When Trials Don’t Meet: A Retrospective Statistical Analysis Using Matching-Adjusted Indirect Comparison (MAIC) and Individual Patient Data (IPD) to Compare Catiolanze® With Other Preservative-Free (PF) Latanoprost in Open-Angle Glaucoma (OAG)
Sep 9, 2025, 16:22 PM -
Validating a Medication Adherence Index in Large Urban Population
Sep 9, 2025, 16:22 PM -
Digital Health Literacy, Engagement, and the Economics of Health Behavior: Evidence from the US HINTS Survey
Sep 9, 2025, 16:22 PM -
The Clinical and Economic Impact of the Introduction of Emicizumab as Prophylactic Treatment for Hemophilia A Patients in Greece
Sep 9, 2025, 16:22 PM -
Early Access Programs and Pricing and Reimbursement Agreements of Orphan Medicines in Portugal
Sep 9, 2025, 16:22 PM -
Health Technologies Using Artificial Intelligence: What Is Being Assessed in the UK by NICE?
Sep 9, 2025, 16:22 PM -
Applying the Delphi Method: A Scoping Review in Healthcare Decision Making and HEOR
Sep 9, 2025, 16:22 PM -
Assessing Public Health and Economic Benefits of Nirsevimab or RSVpreF for Preventing RSV-Related Outcomes in Japanese Infants
Sep 9, 2025, 16:22 PM -
Maximizing Acceptance of Patient-Reported Outcome Data in German HTA Decision Making: Results From a Horizon Scan
Sep 9, 2025, 16:22 PM -
Assessing the Feasibility of the Implementation of a Subscription Model Pricing Solution Aimed at Broadening Access to All Eligible Patients Within the HER2 Indication
Sep 9, 2025, 16:22 PM
